Chiral 4-Aryl-β-Amino Acid Synthesis with Low-Loading BIBOP-Rh Catalysts

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preparing chiral β-amino acid derivatives for synthesizing sitagliptin, such as those using rhodium catalysts or Josiphos ligands, face issues with high costs, low enantiomeric excess (ee values), and inefficient yields, making them uneconomical for industrial applications.

Innovation Solution

A method involving the hydrogenation of enamine compounds using a catalyst containing transition metal rhodium and BIBOP ligands in specific organic solvents, with optimized conditions such as pressure, temperature, and reaction time, to produce chiral 4-aryl-β-amino acid derivatives with high purity and yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If asymmetric catalysis of enamines is performed using rhodium catalysts and Josiphos ligands, then chiral β-amino acid derivatives can be obtained, but the cost is high, the amount of catalyst required is large, and the enantiomeric excess (ee) values are relatively low

Engineering Contradiction:
Improveenantiomeric excess (ee) valueVSAvoidcost and catalyst amount
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent changes the chemical parameters by replacing Josiphos ligands with BIBOPs ligands and adjusting the catalyst composition to [Rh(NBD)2]BF4. This parameter change results in significantly improved enantiomeric excess (ee values up to 99.9%) while reducing the catalyst loading requirement to 0.1-1.0 mol%, thereby resolving the contradiction between manufacturing precision and ease of manufacture

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a composite catalyst system consisting of [Rh(NBD)2]BF4 salt combined with BIBOPs ligands. This composite material approach creates a synergistic effect where the rhodium center and the chiral BIBOPs ligand work together to achieve both high enantioselectivity and catalytic efficiency, reducing the amount of catalyst needed while maintaining high ee values

Inventive Principle:
Principle #40Composite materials

2Productivity

If asymmetric hydrogenation of enamines is performed using BINAP-RuCl2 as a catalyst, then chiral β-amino acid derivatives can be obtained, but the ee values and yields are relatively low

Engineering Contradiction:
ImproveyieldVSAvoidenantiomeric excess (ee) value
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent changes the catalyst system from BINAP-RuCl2 to [Rh(NBD)2]BF4 combined with BIBOPs ligands. This parameter change simultaneously improves both yield (up to 99%) and enantiomeric excess (up to 99.9%), resolving the contradiction between productivity and manufacturing precision by selecting a more effective catalyst combination

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If asymmetric hydrogenation of enamines is performed using TangPhosRh(COD)BF4 as a catalyst, then the ee value and yield are relatively higher, but the cost of the catalyst ligand is higher and the commercial source is unstable

Engineering Contradiction:
Improveenantiomeric excess (ee) valueVSAvoidcommercial source stability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent replaces the expensive and commercially unstable TangPhos ligand with BIBOPs ligands, which are more economically viable and have stable commercial availability. The BIBOPs ligand system maintains high enantiomeric excess (ee values up to 99.9%) while being more cost-effective and reliably sourced, resolving the contradiction between manufacturing precision and reliability

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high stereoselectivity and yield, up to 99.9% purity, and is economically viable for industrial applications.

Implementation Method 1

hydrogenating an enamine compound having a structure as shown in Formula III in an organic solvent in the presence of a catalyst containing a transition metal rhodium and BIBOPs

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

hydrogenating an enamine compound having a structure as shown in Formula III in an organic solvent in the presence of a catalyst containing a transition metal rhodium and BIBOPs

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Data Source

PatentUS12534427B2Method for preparing chiral 4-aryl-β-amino acid derivative
Publication Date: 2026.01.27 ZHE JIANG MEDICINE CO LTD XINCHANG PHARMA FAB
  • US12534427B2 patent drawing
  • US12534427B2 patent drawing
  • US12534427B2 patent drawing

AI summary

The present invention provides a method for preparing a chiral 4-aryl-β-amino acid derivative. The preparation method comprises hydrogenating an enamine compound having a structure as shown in Formula III in an organic solvent in the presence of a catalyst containing a transition metal and BIBOPs. The preparation method of the present invention uses a small amount of a selected asymmetric catalyst, and has a simple operation, mild reaction conditions, a high yield, a high stereoselectivity, and better industrial application and economic values.